StonvexLoading…
StonvexStonvexStonvexCore line items from IRIX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-03 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 | Q1 2025 2025-03-29 |
|---|---|---|---|---|
Revenue | $52.67M | $37.95M | $25.47M | $11.90M |
Operating Income | $-2.57M | $-2.56M | $-1.15M | $-205.00K |
Net Income | $-4.44M | $-4.25M | $-2.68M | $-1.69M |
EPS (Diluted) | $-0.26 | $-0.25 | $-0.16 | $-0.10 |
Total Assets | $29.15M | $28.35M | $31.59M | $34.24M |
Total Liabilities | $24.23M | $23.67M | $25.53M | $27.38M |
Cash & Equivalents | $6.03M | $5.57M | $6.78M | $7.24M |
Free Cash Flow OCF − CapEx | $-2.26M | $-2.74M | $-1.57M | $-1.16M |
Shares Outstanding | 17.31M | 17.05M | 16.81M | 16.79M |